Display options
Cite
Deibert J, Kühner D, Stahl M, et al. The Peptidoglycan Pattern of Staphylococcus carnosus TM300-Detailed Analysis and Variations Due to Genetic and Metabolic Influences. Antibiotics (Basel). 2016;5(4)doi: 10.3390/antibiotics5040033.
Deibert, J., Kühner, D., Stahl, M., Koeksoy, E., & Bertsche, U. (2016). The Peptidoglycan Pattern of Staphylococcus carnosus TM300-Detailed Analysis and Variations Due to Genetic and Metabolic Influences. Antibiotics (Basel, Switzerland), 5(4), . https://doi.org/10.3390/antibiotics5040033
Deibert, Julia, et al. "The Peptidoglycan Pattern of Staphylococcus carnosus TM300-Detailed Analysis and Variations Due to Genetic and Metabolic Influences." Antibiotics (Basel, Switzerland) vol. 5,4 (2016). doi: https://doi.org/10.3390/antibiotics5040033
Deibert J, Kühner D, Stahl M, Koeksoy E, Bertsche U. The Peptidoglycan Pattern of Staphylococcus carnosus TM300-Detailed Analysis and Variations Due to Genetic and Metabolic Influences. Antibiotics (Basel). 2016 Sep 23;5(4). doi: 10.3390/antibiotics5040033. PMID: 27669322; PMCID: PMC5187514.
Copy Download .nbib Format: NLM
Share it on

Antibiotics (Basel). 2016 Sep 23;5(4). doi: 10.3390/antibiotics5040033.

The Peptidoglycan Pattern of Staphylococcus carnosus TM300-Detailed Analysis and Variations Due to Genetic and Metabolic Influences.

Antibiotics (Basel, Switzerland)

Julia Deibert, Daniel Kühner, Mark Stahl, Elif Koeksoy, Ute Bertsche

Affiliations

  1. Interfaculty Institute of Microbiology and Infection Medicine Tübingen (IMIT) - Microbial Genetics, University of Tuebingen, Auf der Morgenstelle 28 E, 72076 Tuebingen, Germany. [email protected].
  2. Interfaculty Institute of Microbiology and Infection Medicine Tübingen (IMIT) - Infection Biology, University of Tuebingen, Auf der Morgenstelle 28 E, 72076 Tuebingen, Germany. [email protected].
  3. Center for Plant Molecular Biology (ZMBP), University of Tuebingen, Auf der Morgenstelle 32, 72076 Tuebingen, Germany. [email protected].
  4. Interfaculty Institute of Microbiology and Infection Medicine Tübingen (IMIT) - Microbial Genetics, University of Tuebingen, Auf der Morgenstelle 28 E, 72076 Tuebingen, Germany. [email protected].
  5. Interfaculty Institute of Microbiology and Infection Medicine Tübingen (IMIT) - Microbial Genetics, University of Tuebingen, Auf der Morgenstelle 28 E, 72076 Tuebingen, Germany. [email protected].
  6. Interfaculty Institute of Microbiology and Infection Medicine Tübingen (IMIT) - Infection Biology, University of Tuebingen, Auf der Morgenstelle 28 E, 72076 Tuebingen, Germany. [email protected].

PMID: 27669322 PMCID: PMC5187514 DOI: 10.3390/antibiotics5040033

Abstract

The Gram-positive bacterium Staphylococcus carnosus (S. carnosus) TM300 is an apathogenic staphylococcal species commonly used in meat starter cultures. As with all Gram-positive bacteria, its cytoplasmic membrane is surrounded by a thick peptidoglycan (PGN) or murein sacculus consisting of several layers of glycan strands cross-linked by peptides. In contrast to pathogenic staphylococci, mainly Staphylococcus aureus (S. aureus), the chemical composition of S. carnosus PGN is not well studied so far. UPLC/MS analysis of enzymatically digested S. carnosus TM300 PGN revealed substantial differences in its composition compared to the known pattern of S. aureus. While in S. aureus the uncross-linked stem peptide consists of a pentapeptide, in S. carnosus, this part of the PGN is shortened to tripeptides. Furthermore, we found the PGN composition to vary when cells were incubated under certain conditions. The collective overproduction of HlyD, FtsE and FtsX-a putative protein complex interacting with penicillin-binding protein 2 (PBP2)-caused the reappearance of classical penta stem peptides. In addition, under high sugar conditions, tetra stem peptides occur due to overflow metabolism. This indicates that S. carnosus TM300 cells adapt to various conditions by modification of their PGN.

Keywords: CcpA; FtsEX; S. carnosus; UPLC/MS; carboxypeptidases; muropeptides; peptidoglycan

Conflict of interest statement

The authors declare no conflict of interest.

References

  1. Bioinformatics. 2014 Mar 15;30(6):884-6 - PubMed
  2. Lipid Insights. 2016 Jan 13;8(Suppl 1):21-31 - PubMed
  3. Nat Rev Microbiol. 2007 Dec;5(12 ):917-27 - PubMed
  4. J Bacteriol. 2005 Mar;187(5):1815-24 - PubMed
  5. J Biol Chem. 1992 Jun 5;267(16):11248-54 - PubMed
  6. FEMS Microbiol Lett. 1994 Apr 1;117(2):131-6 - PubMed
  7. Antimicrob Agents Chemother. 2016 Mar 25;60(4):2391-401 - PubMed
  8. Microbiologyopen. 2016 Oct;5(5):738-752 - PubMed
  9. J Appl Microbiol. 2007 Mar;102(3):736-47 - PubMed
  10. Structure. 2014 Jul 8;22(7):949-60 - PubMed
  11. Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):E1061-9 - PubMed
  12. Mol Microbiol. 1991 Mar;5(3):575-84 - PubMed
  13. Mol Microbiol. 2013 Sep;89(6):1069-83 - PubMed
  14. J Bacteriol. 2004 Feb;186(3):785-93 - PubMed
  15. Science. 2014 Jul 11;345(6193):220-2 - PubMed
  16. J Bacteriol. 1977 Jan;129(1):343-50 - PubMed
  17. Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):E1052-60 - PubMed
  18. Gene. 1979 May;6(1):23-8 - PubMed
  19. J Gen Microbiol. 1963 Nov;33:213-29 - PubMed
  20. J Music Ther. 2011 Spring;48(1):55-73 - PubMed
  21. Infect Immun. 2006 Aug;74(8):4598-604 - PubMed
  22. Biochemistry. 1971 May 25;10(11):2170-5 - PubMed
  23. EMBO J. 2011 Apr 20;30(8):1425-32 - PubMed
  24. Nat Commun. 2015 Aug 17;6:8055 - PubMed
  25. Mol Microbiol. 1999 Feb;31(3):983-93 - PubMed
  26. J Biol Chem. 2014 May 23;289(21):14707-18 - PubMed
  27. J Bacteriol. 2007 May;189(9):3525-31 - PubMed
  28. Mol Microbiol. 2006 Nov;62(3):811-22 - PubMed
  29. PLoS Pathog. 2012 Jan;8(1):e1002508 - PubMed
  30. Antimicrob Agents Chemother. 2008 Nov;52(11):3955-66 - PubMed
  31. MBio. 2013 Jul 16;4(4):null - PubMed
  32. J Bacteriol. 2000 Feb;182(4):1074-9 - PubMed
  33. Appl Environ Microbiol. 2008 Mar;74(5):1316-23 - PubMed
  34. Bacteriol Rev. 1972 Dec;36(4):407-77 - PubMed
  35. Mol Microbiol. 2005 Mar;55(6):1631-45 - PubMed
  36. J Biol Chem. 1988 Jul 25;263(21):10088-95 - PubMed
  37. J Bacteriol. 2001 Nov;183(22):6525-31 - PubMed
  38. Appl Environ Microbiol. 2012 Feb;78(4):1148-56 - PubMed
  39. Appl Environ Microbiol. 2004 Nov;70(11):6887-91 - PubMed
  40. FEMS Microbiol Lett. 1996 Apr 1;137(2-3):279-84 - PubMed
  41. Curr Genet. 2016 Jul 8;:null - PubMed
  42. FEMS Microbiol Lett. 1991 Mar 1;62(2-3):253-7 - PubMed
  43. FEMS Microbiol Lett. 1997 Jun 1;151(1):1-8 - PubMed
  44. Appl Environ Microbiol. 2009 Feb;75(3):811-22 - PubMed
  45. Microbiol Mol Biol Rev. 1998 Dec;62(4):1079-93 - PubMed
  46. J Bacteriol. 1977 Jan;129(1):217-24 - PubMed
  47. Science. 2007 Mar 9;315(5817):1402-5 - PubMed
  48. Nat Methods. 2009 May;6(5):343-5 - PubMed
  49. J Biol Chem. 1992 Jun 5;267(16):11255-9 - PubMed
  50. Antimicrob Agents Chemother. 2006 Apr;50(4):1183-94 - PubMed
  51. J Gen Microbiol. 1962 Nov;29:531-5 - PubMed
  52. Mol Microbiol. 2005 Feb;55(3):778-87 - PubMed
  53. J Bacteriol. 2014 Dec;196(23):4111-9 - PubMed
  54. Int J Med Microbiol. 2010 Feb;300(2-3):104-8 - PubMed
  55. Mol Gen Genet. 1992 Jul;234(1):155-63 - PubMed
  56. Mol Microbiol. 2005 Feb;55(3):799-807 - PubMed
  57. Sci Rep. 2014 Dec 16;4:7494 - PubMed
  58. Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10886-91 - PubMed
  59. PLoS Pathog. 2012 Jan;8(1):e1002509 - PubMed
  60. Biochemistry. 2012 Oct 16;51(41):8143-53 - PubMed
  61. Proc Natl Acad Sci U S A. 1998 May 12;95(10):5752-6 - PubMed
  62. PLoS One. 2013;8(2):e57579 - PubMed

Publication Types